{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:39:52Z","timestamp":1782401992501,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,11,25]],"date-time":"2010-11-25T00:00:00Z","timestamp":1290643200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s00280-010-1522-7","type":"journal-article","created":{"date-parts":[[2010,11,24]],"date-time":"2010-11-24T11:24:32Z","timestamp":1290597872000},"page":"531-538","source":"Crossref","is-referenced-by-count":19,"title":["Safety and pharmacokinetics of intrathecal administration of pemetrexed in rats"],"prefix":"10.1007","volume":"68","author":[{"given":"Jong-Mu","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Hyun","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Yong","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohee","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Youn","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youn-Lim","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Seok","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keunchil","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung-Ju","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,25]]},"reference":[{"key":"1522_CR1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0306-4522(88)90150-9","volume":"26","author":"CD Balaban","year":"1988","unstructured":"Balaban CD, O\u2019Callaghan JP, Billingsley ML (1988) Trimethyltin-induced neuronal damage in the rat brain: comparative studies using silver degeneration stains, immunocytochemistry and immunoassay for neuronotypic and gliotypic proteins. Neuroscience 26:337\u2013361","journal-title":"Neuroscience"},{"key":"1522_CR2","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJM197310112891503","volume":"289","author":"WA Bleyer","year":"1973","unstructured":"Bleyer WA, Drake JC, Chabner BA (1973) Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia. N Engl J Med 289:770\u2013773","journal-title":"N Engl J Med"},{"key":"1522_CR3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1078\/0940-2993-00264","volume":"54","author":"A Bueno","year":"2003","unstructured":"Bueno A, De Olmos S, Heimer L, De Olmos J (2003) NMDA-antagonist MK-801-induced neuronal degeneration in Wistar rat brain detected by the Amino-Cupric-Silver method. Exp Toxicol Pathol 54:319\u2013334","journal-title":"Exp Toxicol Pathol"},{"key":"1522_CR4","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1001\/archneur.1995.00540330094020","volume":"52","author":"MC Chamberlain","year":"1995","unstructured":"Chamberlain MC, Kormanik P, Howell SB, Kim S (1995) Pharmacokinetics of intralumbar DTC-101 for the treatment of leptomeningeal metastases. Arch Neurol 52:912\u2013917","journal-title":"Arch Neurol"},{"key":"1522_CR5","doi-asserted-by":"crossref","unstructured":"Chan DC, Chen V, Helfrich B, Zhang Z, Hirsch F, Ma D, Bunn P (2006) Preclinical studies of pemetrexed and gemcitabine, alone and in combinations, in human lung cancers. AACR Meeting Abstracts 2006:1278b","DOI":"10.1200\/jco.2006.24.18_suppl.17114"},{"key":"1522_CR6","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/jnci\/88.21.1571","volume":"88","author":"KC Chu","year":"1996","unstructured":"Chu KC, Tarone RE, Kessler LG, Ries LAG, Hankey BF, Miller BA, Edwards BK (1996) Recent trends in US breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 88:1571\u20131579","journal-title":"J Natl Cancer Inst"},{"key":"1522_CR7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jchromb.2005.05.037","volume":"825","author":"MI Churchwell","year":"2005","unstructured":"Churchwell MI, Twaddle NC, Meeker LR, Doerge DR (2005) Improving LC-MS sensitivity through increases in chromatographic performance: comparisons of UPLC-ES\/MS\/MS to HPLC-ES\/MS\/MS. J Chromatogr B 825:134\u2013143","journal-title":"J Chromatogr B"},{"key":"1522_CR8","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0b013e3181dc1a69","volume":"74","author":"JLM Clarke","year":"2010","unstructured":"Clarke JLM, Perez HR, Jacks LMM, Panageas KSD, DeAngelis LMM (2010) Leptomeningeal metastases in the MRI era. Neurology 74:1449\u20131454","journal-title":"Neurology"},{"key":"1522_CR9","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1023\/A:1008372529239","volume":"10","author":"C Cripps","year":"1999","unstructured":"Cripps C, Burnell M, Jolivet J, Batist G, Lofters W, Dancey J, Iglesias J, Fisher B, Eisenhauer EA (1999) Phase II study of first-line LY231514 (multi-targeted antifolate) in patients with locally advanced or metastatic colorectal cancer: an NCIC clinical trials group study. Ann Oncol 10:1175\u20131179","journal-title":"Ann Oncol"},{"key":"1522_CR10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1124\/jpet.105.090043","volume":"315","author":"H Dai","year":"2005","unstructured":"Dai H, Chen Y, Elmquist WF (2005) Distribution of the novel antifolate pemetrexed to the brain. J Pharmacol Exp Ther 315:222\u2013229","journal-title":"J Pharmacol Exp Ther"},{"key":"1522_CR11","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0892-0362(94)90033-7","volume":"16","author":"JS Olmos de","year":"1994","unstructured":"de Olmos JS, Beltramino CA, de Lorenzo S (1994) Use of an amino-cupric-silver technique for the detection of early and semiacute neuronal degeneration caused by neurotoxicants, hypoxia, and physical trauma. Neurotoxicol Teratol 16:545\u2013561","journal-title":"Neurotoxicol Teratol"},{"key":"1522_CR12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1124\/mol.104.009373","volume":"68","author":"E Giovannetti","year":"2005","unstructured":"Giovannetti E, Mey V, Nannizzi S, Pasqualetti G, Marini L, Del Tacca M, Danesi R (2005) Cellular and pharmacogenetics foundation of synergistic interaction of pemetrexed and gemcitabine in human non\u2013small-cell lung cancer cells. Mol Pharmacol 68:110\u2013118","journal-title":"Mol Pharmacol"},{"key":"1522_CR13","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1200\/JCO.2004.08.163","volume":"22","author":"N Hanna","year":"2004","unstructured":"Hanna N, Shepherd FA, Fossella FV, Pereira JR, De Marinis F, von Pawel J, Gatzemeier U, Tsao TCY, Pless M, Muller T, Lim H-L, Desch C, Szondy K, Gervais R, Shaharyar S, Manegold C, Paul S, Paoletti P, Einhorn L, Bunn PA Jr (2004) Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 22:1589\u20131597","journal-title":"J Clin Oncol"},{"key":"1522_CR14","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1200\/JCO.1987.5.10.1655","volume":"5","author":"R Hitchins","year":"1987","unstructured":"Hitchins R, Bell D, Woods R, Levi J (1987) A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J Clin Oncol 5:1655\u20131662","journal-title":"J Clin Oncol"},{"key":"1522_CR15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000205386","volume":"76","author":"HS Kim","year":"2009","unstructured":"Kim HS, Park K, Jun HJ, Yi SY, Lee J, Ahn JS, Park YH, Kim S, Lee S, Ahn MJ (2009) Comparison of survival in advanced non-small cell lung cancer patients in the pre- and post-gefitinib eras. Oncology 76:239\u2013246","journal-title":"Oncology"},{"key":"1522_CR16","first-page":"977","volume":"49","author":"KL Kooistra","year":"1989","unstructured":"Kooistra KL, Rodriguez M, Powis G (1989) Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat. Cancer Res 49:977\u2013982","journal-title":"Cancer Res"},{"key":"1522_CR17","first-page":"317","volume":"46","author":"KL Kooistra","year":"1986","unstructured":"Kooistra KL, Rodriguez M, Powis G, Yaksh TL, Harty GJ, Hilton JF, Laws ER (1986) Development of experimental models for meningeal neoplasia using intrathecal injection of 9L gliosarcoma and walker 256 carcinosarcoma in the rat. Cancer Res 46:317\u2013323","journal-title":"Cancer Res"},{"key":"1522_CR18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.pbb.2010.05.021","volume":"96","author":"F Li","year":"2010","unstructured":"Li F, Gong Q-H, Wu Q, Lu Y-F, Shi J-S (2010) Icariin isolated from Epimedium brevicornum maxim attenuates learning and memory deficits induced by d-galactose in rats. Pharmacol Biochem Behav 96:301\u2013305","journal-title":"Pharmacol Biochem Behav"},{"key":"1522_CR19","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/sj.bjc.6603321","volume":"95","author":"K Nakagawa","year":"2006","unstructured":"Nakagawa K, Kudoh S, Matsui K, Negoro S, Yamamoto N, Latz JE, Adachi S, Fukuoka M (2006) A phase I study of pemetrexed (LY231514) supplemented with folate and vitamin B12 in Japanese patients with solid tumours. Br J Cancer 95:677\u2013682","journal-title":"Br J Cancer"},{"issue":"Suppl 4","key":"1522_CR20","doi-asserted-by":"crossref","first-page":"iv285","DOI":"10.1093\/annonc\/mdh941","volume":"15","author":"N Pavlidis","year":"2004","unstructured":"Pavlidis N (2004) The diagnostic and therapeutic management of leptomeningeal carcinomatosis. Ann Oncol 15(Suppl 4):iv285\u2013iv291","journal-title":"Ann Oncol"},{"key":"1522_CR21","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/cncr.11279","volume":"97","author":"L Paz-Ares","year":"2003","unstructured":"Paz-Ares L, Bezares S, Tabernero JM, Castellanos D, Cortes-Funes H (2003) Review of a promising new agent\u2014pemetrexed disodium. Cancer 97:2056\u20132063","journal-title":"Cancer"},{"key":"1522_CR22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ana.410250408","volume":"25","author":"PC Phillips","year":"1989","unstructured":"Phillips PC, Thaler HT, Allen JC, Rottenberg DA (1989) High-dose leucovorin reverses acute high-dose methotrexate neurotoxicity in the rat. Ann Neurol 25:365\u2013372","journal-title":"Ann Neurol"},{"key":"1522_CR23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00000539-200507000-00029","volume":"101","author":"YYM Poon","year":"2005","unstructured":"Poon YYM, Chang AYWP, Ko SFM, Chan SHHP (2005) An improved procedure for catheterization of the thoracic spinal subarachnoid space in the rat. Anesth Analg 101:155\u2013160","journal-title":"Anesth Analg"},{"key":"1522_CR24","first-page":"1982","volume":"37","author":"DG Poplack","year":"1977","unstructured":"Poplack DG, Bleyer WA, Wood JH, Kostolich M, Savitch JL, Ommaya AK (1977) A primate model for study of methotrexate pharmacokinetics in the central nervous system. Cancer Res 37:1982\u20131985","journal-title":"Cancer Res"},{"key":"1522_CR25","first-page":"437","volume":"19","author":"RM Schultz","year":"1999","unstructured":"Schultz RM, Patel VF, Worzalla JF, Shih C (1999) Role of thymidylate synthase in the antitumor activity of the multitargeted antifolate, LY231514. Anticancer Res 19:437\u2013443","journal-title":"Anticancer Res"},{"key":"1522_CR26","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1203\/00006450-199404000-00007","volume":"35","author":"A Schunior","year":"1994","unstructured":"Schunior A, Mullenix PJ, Zengel AE, Landy H, Howes A, Tarbell NJ (1994) Radiation effects on growth are altered in rats by prednisone and methotrexate. Pediatr Res 35:416\u2013423","journal-title":"Pediatr Res"},{"key":"1522_CR27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbr.2007.08.004","volume":"186","author":"R Seigers","year":"2008","unstructured":"Seigers R, Schagen SB, Beerling W, Boogerd W, van Tellingen O, van Dam FSAM, Koolhaas JM, Buwalda B (2008) Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat. Behav Brain Res 186:168\u2013175","journal-title":"Behav Brain Res"},{"key":"1522_CR28","first-page":"1116","volume":"57","author":"C Shih","year":"1997","unstructured":"Shih C, Chen VJ, Gossett LS, Gates SB, MacKellar WC, Habeck LL, Shackelford KA, Mendelsohn LG, Soose DJ, Patel VF, Andis SL, Bewley JR, Rayl EA, Moroson BA, Beardsley GP, Kohler W, Ratnam M, Schultz RM (1997) LY231514, a Pyrrolo[2, 3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes. Cancer Res 57:1116\u20131123","journal-title":"Cancer Res"},{"key":"1522_CR29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3816\/CBC.2001.n.010","volume":"2","author":"M Spielmann","year":"2001","unstructured":"Spielmann M, Martin M, Namer M, duBois A, Unger C, Dodwell DJ (2001) Activity of pemetrexed (ALIMTA, multitargeted antifolate, LY231514) in metastatic breast cancer patients previously treated with an anthracycline and a taxane: an interim analysis. Clin Breast Cancer 2:47\u201351","journal-title":"Clin Breast Cancer"},{"key":"1522_CR30","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00280-006-0285-7","volume":"59","author":"SL Stapleton","year":"2007","unstructured":"Stapleton SL, Reid JM, Thompson PA, Ames MM, McGovern RM, McGuffey L, Nuchtern J, Dauser R, Blaney SM (2007) Plasma and cerebrospinal fluid pharmacokinetics of pemetrexed after intravenous administration in non-human primates. Cancer Chemother Pharmacol 59:461\u2013466","journal-title":"Cancer Chemother Pharmacol"},{"key":"1522_CR31","unstructured":"US Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research. (2005) Guidance for industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. Pharmacology and Toxicology"},{"key":"1522_CR32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0165-0270(02)00033-X","volume":"116","author":"MP Berg van den","year":"2002","unstructured":"van den Berg MP, Romeijn SG, Verhoef JC, Merkus FWHM (2002) Serial cerebrospinal fluid sampling in a rat model to study drug uptake from the nasal cavity. J Neurosci Methods 116:99\u2013107","journal-title":"J Neurosci Methods"},{"key":"1522_CR33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11060-008-9758-3","volume":"93","author":"F Waki","year":"2009","unstructured":"Waki F, Ando M, Takashima A, Yonemori K, Nokihara H, Miyake M, Tateishi U, Tsuta K, Shimada Y, Fujiwara Y, Tamura T (2009) Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors. J Neurooncol 93:205\u2013212","journal-title":"J Neurooncol"},{"key":"1522_CR34","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7","volume":"49","author":"WR Wasserstrom","year":"1982","unstructured":"Wasserstrom WR, Glass JP, Posner JB (1982) Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 49:759\u2013772","journal-title":"Cancer"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-010-1522-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-010-1522-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-010-1522-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T08:19:24Z","timestamp":1685866764000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-010-1522-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,25]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["1522"],"URL":"https:\/\/doi.org\/10.1007\/s00280-010-1522-7","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,25]]}}}